imugene thrilled as first patient dosed in phase 1 oasis trial
Published 1 year ago • 552 plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
4:45
imugene delighted as first cohort 3 patient dosed in checkvacc trial
-
6:40
imugene doses first patient in vaxinia phase 1 trial
-
5:00
imugene doses first patient in intravenous monotherapy arm of phase 1 clinical trial
-
4:00
first patient dosed in imugene's pd1-vaxx combination trial
-
5:00
imugene doses first patient in intravenous monotherapy arm of phase 1 clinical trial
-
26:16
a californian cancer killer professor yuman fong and his work with imugene
-
56:27
pediatric diabetes - prof. abdulmoein al-agha
-
20:11
interview with the cf33 oncolytic virus inventor - imugene (imu)
-
0:50
imugene has announced the first patient dosed in the combination cohort
-
5:20
imugene welcomes dosing of first patient in nextherizon phase 2 clinical trial
-
6:43
imugene's leslie chong welcomes first patient dosed in checkvacc trial
-
5:15
imugene | first patients dosed in vaxinia mast combination study
-
5:40
imugene secures ind approval for first-in-class oncarlytics trial
-
6:29
imugene finishes phase 1a monotherapy dose escalation of pd1 vaxx
-
4:56
asx to rebound. imugene trials first patient in nextherizon
-
4:15
imugene talks vaxinia mast trial and corporate ambition
-
4:30
imugene md shares with juststocks plans for phase 1 oncarlytics combination study
-
20:57
imugene (asx: imu) - discussing imu's 2022 biotech opportunity
-
1:07:06
#aimi21 | session 1: role of ai in diagnostic excellence